Regeneron spending $1.8B to expand footprint in New York

For this year Regeneron Pharmaceuticals 's (located in Tarrytown) revenue will be around 12.2 billion USD. This is according to the average of the analysts' estimates. This is rather significant more than 2021's revenue of 8.5 billion USD.

Historical revenues and results Regeneron Pharmaceuticals plus estimates 2021

The analysts expect for 2021 a net profit of 5.24 billion USD. For this year the consensus of the result per share is a profit of 47.62 USD. The price/earnings-ratio is then 12.07.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the pharmaceutical companies equals an attractive1.52 percent.

Regeneron Pharmaceuticals 's market value equals around 62.3 billion . -9

Historical stock prices Regeneron Pharmaceuticals

On Friday, the stock closed at 574.61 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.